products
Treatment protocols
Adverse transfusion reactions
Reading list
CHAPTER 55: Anticoagulation‐Related Bleeding
Background
Prevention
Diagnosis
Treatment
Prognosis
Reading list
Guidelines
CHAPTER 56: Coagulopathy and Thrombocytopenia
Background
Prevention
Diagnosis
Treatment
Special populations
Prognosis
Reading list
Guidelines
CHAPTER 57: Venous Thromboembolism and Pulmonary Embolism
Background
Prevention
Diagnosis
Treatment
Special populations
Prognosis
Reading list
Guidelines
Images
CHAPTER 58: Oncologic Emergencies
Background
Prevention
Diagnosis
Treatment
Prognosis
Reading list
Guidelines
17 Index
List of Tables
1 Chapter 1Table 1.1 Predictors of difficulties with mask ventilation and/or intubation.
2 Chapter 2Table 2.1 Richmond Agitation‐Sedation Scale.Table 2.2 Riker Sedation‐Agitation Scale.
3 Chapter 4Table 4.1 Features of ultrasound physics.Table 4.2 Probe types.Table 4.3 Intravascular volume estimation .Table 4.4 Features of cardiogenic pulmonary edema and non‐cardiogenic lung injury...Table 4.5 RUSH exam protocol.
4 Chapter 6Table 6.1 Risks and benefits of tracheostomy.
5 Chapter 7Table 7.1 Determining patients’ ideal body weight (IBW).*Table 7.2 Determining protein requirements (g/day).Table 7.3 Determining caloric and macronutrient requirements (g/day): carbohydrat...Table 7.4 Determining caloric and macronutrient requirements (g/day): lipids and ...
6 Chapter 9Table 9.1 MACOCHA score calculation worksheet.
7 Chapter 11Table 11.1 Waveform components.Table 11.2 Echocardiography views.
8 Chapter 12Table 12.1 Different forms of shock states.Table 12.2 Action of vasoactive medications.
9 Chapter 17Table 17.1 Vasoactive medications.
10 Chapter 19Table 19.1 PEA evaluation.Table 19.2 Inclusion and exclusion criteria for TTM therapy after cardiac arre...
11 Chapter 20Table 20.1 Potential causes of false high and low values in pulse oximetry.Table 20.2 Interpretation of capnographs.
12 Chapter 21Table 21.1 Features of hypoxemic and hypercapnic respiratory failure.Table 21.2 Common ventilator modes.
13 Chapter 22Table 22.1 Indications and contraindications for NPPV.Table 22.2 Indications and contraindications for HFNC.
14 Chapter 23Table 23.1 Etiologies of ARDS.Table 23.2 Risk factors for ARDS.
15 Chapter 24Table 24.1 Additional risk factors for asthma and COPD‐related deaths.Table 24.2 Frequently used medications in acute severe asthma and severe AECOPD....
16 Chapter 25Table 25.1 Criteria for a successful SBT.*
17 Chapter 26Table 26.1 Screening tools for delirium .
18 Chapter 27Table 27.1 Classification of hemorrhagic infarction.
19 Chapter 32Table 32.1 Presentation of common toxidromes.
20 Chapter 38Table 38.1 Burn classification.
21 Chapter
